BMJ

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

2 Rheumatology Department, Leiden University Medical Center, Leiden, The Netherlands 3 Rheumatology Department, Maastricht University Medical Center, Maastricht, The Netherlands Background The ...
BMJ

Aerobic walking or strengthening exercise for osteoarthritis of the knee? A systematic review

Academic Rheumatology, Clinical Sciences Building, Nottingham City Hospital, Nottingham, UK Correspondence to: Dr Edward Roddy Academic Rheumatology, Clinical Sciences Building, Nottingham City ...
BMJ

Purine-rich foods intake and recurrent gout attacks

1 Clinical Epidemiology Research and Training Unit, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA 2 Data Coordinating Center, Boston University School of ...
BMJ

Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)

Aims Treating to low disease activity is routine in rheumatoid arthritis, but no comparable goal has been defined for systemic lupus erythematosus (SLE). We sought to define and validate a Lupus Low ...
BMJ

A novel Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean Fever

Objective Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis (PAAND) is a recently described monogenic autoinflammatory disease. The causal p.S242R MEFV mutation disrupts a binding motif ...
BMJ

Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis

Objectives Inflammatory myopathy or myositis is a heterogeneous family of immune-mediated diseases including dermatomyositis (DM), antisynthetase syndrome (AS), immune-mediated necrotising myopathy ...
BMJ

Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study

Correspondence to Dr Burkhard Möller, Department of Rheumatology and Clinical Immunology, Inselspital-University Hospital, Bern 3010, Switzerland; Burkhard.moeller{at}insel.ch Objectives Non-steroidal ...
BMJ

Measurement invariance of the Illness Invalidation Inventory (3*I) across language, rheumatic disease and gender

1 Department of Clinical and Health Psychology, Utrecht University, Utrecht, The Netherlands 2 Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The ...
BMJ

Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1β and tumour necrosis factor α

Objective: To determine whether IL18 has any indirect effects on osteoclastogenesis mediated by T cells in RA synovium, and compare its effects with those of IL1β and TNFα. Methods: Resting T cells ...
BMJ

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations

Correspondence to Professor Désirée van der Heijde, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, Leiden 2300 RC, The Netherlands; mail{at}dvanderheijde.nl The overall ...
BMJ

OP0229 THE GROUP FOR RESEARCH AND ASSESSMENT OF PSORIASIS AND PSORIATIC ARTHRITIS (GRAPPA) TREATMENT RECOMMENDATIONS 2021

Background: Since the 2015 GRAPPA treatment recommendations were published, therapeutic options and management strategies for psoriatic arthritis (PsA) have advanced considerably. Objectives: The goal ...
BMJ

Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis

Background: Patient reported outcome measures used in studies of psoriatic arthritis (PsA) have been found to be inadequate for determining the impact of the disease from the patient’s perspective.